Cargando…
Caspofungin/ceftriaxone/hydroxychloroquine: Brugada syndrome and off-label use: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233628/ http://dx.doi.org/10.1007/s40278-021-97889-6 |
Ejemplares similares
-
Ceftriaxone/heparin/hydroxychloroquine: Thrombocytopenia and off-label use: case report
Publicado: (2020) -
Ceftriaxone/hydroxychloroquine/lopinavir: Lack of efficacy in off-label use: case report
Publicado: (2021) -
Ceftriaxone/cobicistat/darunavir/hydroxychloroquine: Off-label use and lack of efficacy: case report
Publicado: (2022) -
Ceftriaxone/hydroxychloroquine/tocilizumab: QT prolongation, torsade-de-pointes and off label use: case report
Publicado: (2020) -
Azithromycin/hydroxychloroquine/lopinavir/ritonavir: Brugada-like ECG pattern following off-label use: case report
Publicado: (2021)